Episode
Episode 8: The Equity Gap in Diagnostic AI
- Podcast
- From Models to Medicine
- Published
- May 13, 2026
- Duration seconds
- 2540
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/from-models-to-medicine-7769799/episodes/episode-8-the-equity-gap-in-diagnostic-ai/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/from-models-to-medicine-7769799/episode-8-the-equity-gap-in-diagnostic-ai.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, we sit down with Dr. Freddy Nguyen , CEO and co-founder of Nine Diagnostics, whose background spans medicine, pathology, optics, and nanotechnology. Freddy shares how Nine Diagnostics is building a multiomics platform that helps cancer patients find out within days whether their treatment is actually working. We dig into why AI's real power in medicine lies in its ability to connect siloed data across molecular readouts, imaging, and clinical context, and why treating patients as more than just their diagnosis is the only way to build tools that actually hold up in the real world. We also get into the harder conversation: where AI in clinical workflows breaks down. It's a candid, technically grounded conversation about what equitable AI in medicine actually requires.